Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort.
Sascha Louise HeckertJohanna Maria MaassenS le CessieY P M Goekoop-RuitermanMelek Güler-YükselWillem F LemsThomas Wj HuizingaSytske Anne BergstraCornelia F AllaartPublished in: Annals of the rheumatic diseases (2023)
After long-term treatment-to-target, excess mortality occurred in patients with RA after>10 years since treatment start, with smoking as an important risk factor.